건강 상태

16 근거 기반 건강기능식품 연구가 있는 건강 상태

We evaluate supplements across specific hair and scalp conditions. Each condition page ranks ingredients by evidence grade, helping you find what research actually supports for your particular concern.

How We Grade Evidence

각 건강 상태 페이지는 임상 근거의 강도에 따라 건강기능식품 성분의 순위를 매깁니다. 각 등급의 의미는 다음과 같습니다:

Strong Evidence

Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.

Good Evidence

At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.

Some Evidence

Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.

Very Early Research

In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.

산후 탈모

Affects 40-50% of women postpartum

Excessive shedding Thinning around temples Reduced hair density

두피 염증 (모낭염 및 피부염)

Seborrheic dermatitis affects 3-5% of adults; scalp involvement very common

Scalp redness Itching and flaking Pustules around follicles +1

취약 모발 및 손톱 증후군

Affects approximately 20% of the general population

Dry, splitting hair Increased breakage Brittle, peeling nails +1

두피 건선 관련 탈모

45-56% of psoriasis patients have scalp involvement

Thick scales Red patches Itching +1

원형 탈모증

2% lifetime risk

Circular bald patches Exclamation point hairs Nail pitting

영양 결핍성 탈모

Common in restrictive diets and malabsorption conditions

Diffuse thinning Dry dull hair Slow growth +1

철분 결핍성 탈모

Affects up to 60% of premenopausal women with hair loss

Diffuse thinning Increased shedding Fatigue +1

견인성 탈모

Common in certain hairstyle practices

Hairline recession Broken hairs Folliculitis

여성형 탈모

40% of women by age 50

Widening central part Diffuse crown thinning Preserved frontal hairline

휴지기 탈모

Second most common cause of hair loss

Diffuse thinning Excessive shedding Reduced ponytail volume

갑상선 관련 탈모

4-10% of general population has thyroid dysfunction

Diffuse thinning Dry brittle hair Loss of outer eyebrows

노화성 모발 가늘어짐

Near-universal over age 60

Gradual density reduction Finer hair texture Slower growth rate

스트레스성 탈모

Increasingly common; associated with telogen effluvium

Diffuse shedding Hair thinning Slower regrowth

안드로겐성 탈모

50% of men by age 50, 25% of women by age 50

Receding hairline Crown thinning Widening part +1

항암화학요법 유발 탈모

Affects 65-85% of chemotherapy patients depending on regimen

Rapid diffuse shedding Complete scalp hair loss Eyebrow and eyelash loss +1

호르몬성 모발 변화 (PCOS 및 폐경)

PCOS affects 6-12% of women; menopause-related thinning affects 40%+ of postmenopausal women

Diffuse thinning Changes in hair texture Hirsutism (PCOS) +1

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.